US Stock MarketDetailed Quotes

TPST Tempest Therapeutics

Watchlist
  • 0.957
  • -0.193-16.78%
Close Aug 12 16:00 ET
  • 0.982
  • +0.025+2.61%
Post 19:35 ET
24.12MMarket Cap-598P/E (TTM)

Tempest Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
13.80%-5.51M
13.45%-7.19M
11.96%-27.36M
4.69%-6.18M
28.49%-6.49M
24.03%-6.39M
-16.83%-8.3M
-19.71%-31.07M
18.86%-6.48M
23.05%-9.07M
Net income from continuing operations
-26.24%-9.57M
-3.51%-7.9M
17.41%-29.49M
17.74%-7.49M
24.15%-6.79M
17.31%-7.58M
10.07%-7.64M
-26.17%-35.71M
-17.02%-9.1M
-10.32%-8.95M
Depreciation and amortization
86.75%155K
-29.60%88K
-40.28%381K
-60.83%85K
-56.22%88K
-25.89%83K
15.74%125K
70.59%638K
112.75%217K
87.85%201K
Other non cash items
-10.28%410K
0.41%487K
20.00%1.88M
5.57%474K
69.57%468K
-2.77%457K
29.33%485K
6.15%1.57M
20.05%449K
-49.36%276K
Change In working capital
940.67%2.18M
31.80%-1.18M
-408.41%-2.68M
-122.42%-343K
21.15%-820K
207.18%209K
-400.70%-1.72M
241.60%868K
259.38%1.53M
77.52%-1.04M
-Change in prepaid assets
87.69%747K
-35.71%-38K
-78.91%193K
-96.72%41K
72.16%-218K
47.96%398K
-115.73%-28K
611.17%915K
439.02%1.25M
1.76%-783K
-Change in payables and accrued expense
4,896.88%1.6M
33.22%-798K
-185.21%-1.24M
-99.12%5K
-171.05%-81K
14.29%32K
-261.05%-1.2M
139.93%1.45M
328.00%570K
103.27%114K
-Change in other current liabilities
22.62%-171K
32.20%-339K
-8.66%-1.63M
-33.68%-389K
-40.43%-521K
55.08%-221K
-44.09%-500K
-44.33%-1.5M
14.66%-291K
-6.30%-371K
Cash from discontinued investing activities
Operating cash flow
13.80%-5.51M
13.45%-7.19M
11.96%-27.36M
4.69%-6.18M
28.49%-6.49M
24.03%-6.39M
-16.83%-8.3M
-19.71%-31.07M
18.86%-6.48M
23.05%-9.07M
Investing cash flow
Cash flow from continuing investing activities
-112.82%-249K
-265.22%-168K
69.75%-170K
98.03%-7K
0
-23.16%-117K
-1,433.33%-46K
-479.38%-562K
-1,218.52%-356K
-871.43%-108K
Net PPE purchase and sale
-112.82%-249K
-265.22%-168K
69.75%-170K
98.03%-7K
--0
-23.16%-117K
-1,433.33%-46K
-316.30%-562K
-1,218.52%-356K
-350.00%-108K
Cash from discontinued investing activities
Investing cash flow
-112.82%-249K
-265.22%-168K
69.75%-170K
98.03%-7K
--0
-23.16%-117K
-1,433.33%-46K
-479.38%-562K
-1,218.52%-356K
-871.43%-108K
Financing cash flow
Cash flow from continuing financing activities
283.59%4.56M
922.73%450K
212.22%35.6M
826.81%34.35M
-94.00%21K
-91.74%1.19M
-96.86%44K
-80.69%11.4M
-52,411.11%-4.73M
-88.95%350K
Net issuance payments of debt
----
----
--0
----
----
----
----
-131.59%-4.74M
----
----
Net common stock issuance
283.59%4.56M
475.00%253K
301.78%35.6M
286,141.67%34.35M
-94.02%21K
-83.26%1.19M
-96.86%44K
-73.49%8.86M
124.49%12K
-89.87%351K
Proceeds from stock option exercised by employees
--0
--197K
--0
----
----
--0
--0
6,641.67%7.28M
----
----
Cash from discontinued financing activities
Financing cash flow
283.59%4.56M
922.73%450K
212.22%35.6M
826.81%34.35M
-94.00%21K
-91.74%1.19M
-96.86%44K
-80.69%11.4M
-52,411.11%-4.73M
-88.95%350K
Net cash flow
Beginning cash position
40.68%32.77M
25.56%39.67M
-39.03%31.6M
-73.34%11.51M
-65.43%17.97M
-49.50%23.29M
-39.03%31.6M
175.39%51.83M
-27.78%43.16M
-24.06%51.99M
Current changes in cash
77.41%-1.2M
16.87%-6.9M
139.91%8.08M
343.64%28.17M
26.77%-6.47M
-190.69%-5.32M
-45.52%-8.31M
-161.29%-20.23M
-44.13%-11.56M
-2.58%-8.83M
End cash Position
75.65%31.57M
40.68%32.77M
25.56%39.67M
25.56%39.67M
-73.34%11.51M
-65.43%17.97M
-49.50%23.29M
-39.03%31.6M
-39.03%31.6M
-27.78%43.16M
Free cash flow
11.52%-5.76M
11.92%-7.35M
12.98%-27.53M
9.55%-6.18M
29.34%-6.49M
23.50%-6.51M
-17.43%-8.35M
-21.24%-31.63M
14.69%-6.84M
22.29%-9.18M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 13.80%-5.51M13.45%-7.19M11.96%-27.36M4.69%-6.18M28.49%-6.49M24.03%-6.39M-16.83%-8.3M-19.71%-31.07M18.86%-6.48M23.05%-9.07M
Net income from continuing operations -26.24%-9.57M-3.51%-7.9M17.41%-29.49M17.74%-7.49M24.15%-6.79M17.31%-7.58M10.07%-7.64M-26.17%-35.71M-17.02%-9.1M-10.32%-8.95M
Depreciation and amortization 86.75%155K-29.60%88K-40.28%381K-60.83%85K-56.22%88K-25.89%83K15.74%125K70.59%638K112.75%217K87.85%201K
Other non cash items -10.28%410K0.41%487K20.00%1.88M5.57%474K69.57%468K-2.77%457K29.33%485K6.15%1.57M20.05%449K-49.36%276K
Change In working capital 940.67%2.18M31.80%-1.18M-408.41%-2.68M-122.42%-343K21.15%-820K207.18%209K-400.70%-1.72M241.60%868K259.38%1.53M77.52%-1.04M
-Change in prepaid assets 87.69%747K-35.71%-38K-78.91%193K-96.72%41K72.16%-218K47.96%398K-115.73%-28K611.17%915K439.02%1.25M1.76%-783K
-Change in payables and accrued expense 4,896.88%1.6M33.22%-798K-185.21%-1.24M-99.12%5K-171.05%-81K14.29%32K-261.05%-1.2M139.93%1.45M328.00%570K103.27%114K
-Change in other current liabilities 22.62%-171K32.20%-339K-8.66%-1.63M-33.68%-389K-40.43%-521K55.08%-221K-44.09%-500K-44.33%-1.5M14.66%-291K-6.30%-371K
Cash from discontinued investing activities
Operating cash flow 13.80%-5.51M13.45%-7.19M11.96%-27.36M4.69%-6.18M28.49%-6.49M24.03%-6.39M-16.83%-8.3M-19.71%-31.07M18.86%-6.48M23.05%-9.07M
Investing cash flow
Cash flow from continuing investing activities -112.82%-249K-265.22%-168K69.75%-170K98.03%-7K0-23.16%-117K-1,433.33%-46K-479.38%-562K-1,218.52%-356K-871.43%-108K
Net PPE purchase and sale -112.82%-249K-265.22%-168K69.75%-170K98.03%-7K--0-23.16%-117K-1,433.33%-46K-316.30%-562K-1,218.52%-356K-350.00%-108K
Cash from discontinued investing activities
Investing cash flow -112.82%-249K-265.22%-168K69.75%-170K98.03%-7K--0-23.16%-117K-1,433.33%-46K-479.38%-562K-1,218.52%-356K-871.43%-108K
Financing cash flow
Cash flow from continuing financing activities 283.59%4.56M922.73%450K212.22%35.6M826.81%34.35M-94.00%21K-91.74%1.19M-96.86%44K-80.69%11.4M-52,411.11%-4.73M-88.95%350K
Net issuance payments of debt ----------0-----------------131.59%-4.74M--------
Net common stock issuance 283.59%4.56M475.00%253K301.78%35.6M286,141.67%34.35M-94.02%21K-83.26%1.19M-96.86%44K-73.49%8.86M124.49%12K-89.87%351K
Proceeds from stock option exercised by employees --0--197K--0----------0--06,641.67%7.28M--------
Cash from discontinued financing activities
Financing cash flow 283.59%4.56M922.73%450K212.22%35.6M826.81%34.35M-94.00%21K-91.74%1.19M-96.86%44K-80.69%11.4M-52,411.11%-4.73M-88.95%350K
Net cash flow
Beginning cash position 40.68%32.77M25.56%39.67M-39.03%31.6M-73.34%11.51M-65.43%17.97M-49.50%23.29M-39.03%31.6M175.39%51.83M-27.78%43.16M-24.06%51.99M
Current changes in cash 77.41%-1.2M16.87%-6.9M139.91%8.08M343.64%28.17M26.77%-6.47M-190.69%-5.32M-45.52%-8.31M-161.29%-20.23M-44.13%-11.56M-2.58%-8.83M
End cash Position 75.65%31.57M40.68%32.77M25.56%39.67M25.56%39.67M-73.34%11.51M-65.43%17.97M-49.50%23.29M-39.03%31.6M-39.03%31.6M-27.78%43.16M
Free cash flow 11.52%-5.76M11.92%-7.35M12.98%-27.53M9.55%-6.18M29.34%-6.49M23.50%-6.51M-17.43%-8.35M-21.24%-31.63M14.69%-6.84M22.29%-9.18M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg